Funding for this research was provided by:
Received: 13 January 2022
Accepted: 18 April 2022
First Online: 30 April 2022
: This study was approved by the Ethics Committee of the University of Bologna.
: The authors provide consent for publication.
: R. Tonelli and A. Pession are BIOGENERA shareholders. S. Raieli, C. Amadesi, D. Bartolucci, S. Bortolotti, S. Angelucci, S. Lampis, A. Scardovi, G. Nieddu, and L. Cerisoli are employed at BIOGENERA. The authors declare no potential conflicts of interest.